Market Insights Health OTC Pharmaceuticals

Other OTC Pharmaceuticals

Indonesia

In Indonesia, the revenue in the Other OTC Pharmaceuticals market reached US$109.30m in 2024.
It is projected to experience an annual growth rate of 2.04% (CAGR 2024-2029).
When compared to other countries worldwide, the in the United States generates the highest revenue with US$7,171.00m in 2024.
Considering the population size, the per person revenue amounts to US$0.39 in 2024.
Indonesia's Other OTC Pharmaceuticals market is experiencing a surge in demand for traditional herbal remedies.

Key regions: United States, Brazil, Europe, Canada, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Other OTC Pharmaceuticals market in Indonesia is experiencing significant growth and development.

Customer preferences: Indonesian consumers have shown a strong preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience of purchasing these products without a prescription, the lower cost compared to prescription medications, and the increasing awareness and importance of self-care and preventive health measures among the population. Additionally, the availability of a wide range of OTC pharmaceutical products in local pharmacies and drugstores has also contributed to the growing demand.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals market in Indonesia is the increasing demand for natural and herbal remedies. Indonesian consumers have a long-standing tradition of using traditional herbal medicines, and this trend has continued to grow in recent years. The preference for natural and herbal remedies can be attributed to the perception that they are safer, have fewer side effects, and are more aligned with traditional cultural practices. As a result, there has been a surge in the availability and sales of herbal OTC pharmaceutical products in the market.Another trend in the market is the rising popularity of OTC pharmaceutical products for specific health conditions. Indonesian consumers are becoming more proactive in managing their health and are seeking OTC products that target specific ailments or conditions. This includes products for pain relief, cough and cold, digestive health, and skincare. Manufacturers have responded to this trend by introducing a wide range of specialized OTC pharmaceutical products to cater to the diverse needs of consumers.

Local special circumstances: Indonesia has a large and growing population, which provides a significant customer base for the OTC Pharmaceuticals market. The country's middle class is expanding, leading to increased purchasing power and affordability of OTC products. Additionally, the government has implemented various healthcare policies and programs to improve access to healthcare services, including OTC pharmaceutical products. This has further fueled the demand for OTC products in the country.

Underlying macroeconomic factors: The Indonesian economy has been growing steadily in recent years, with rising disposable incomes and an expanding middle class. This has contributed to increased consumer spending on healthcare products, including OTC pharmaceuticals. Additionally, advancements in technology and e-commerce have made it easier for consumers to access and purchase OTC products online, further driving market growth.In conclusion, the Other OTC Pharmaceuticals market in Indonesia is experiencing significant growth and development due to customer preferences for convenience and affordability, the increasing demand for natural and herbal remedies, the popularity of specialized OTC products, the large and growing population, and the favorable macroeconomic factors. This presents opportunities for both local and international manufacturers to tap into the growing market and cater to the diverse needs of Indonesian consumers.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.